Paul Smith
11PUBLICATIONS
110CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Apr 17, 2024
Overcoming Osimertinib Resistance with AKT Inhibition in EGFRm-Driven Non-Small Cell Lung Cancer with PIK3CA/PTEN Alterations.Ursula Grazini, Aleksandra Markovets, Lucy Ireland
|Mar 08, 2024
Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations.Azadeh C Bashi, Elizabeth A Coker, Krishna C Bulusu
|Mar 27, 2023
Pharmaceutical Reactivation of Attenuated Apoptotic Pathways Leads to Elimination of Osimertinib Drug-Tolerant Cells.Matthew J Martin, Nicolas Floc'h, Matthias Pfeifer
|Dec 27, 2022
The landscape of therapeutic vulnerabilities in EGFR inhibitor osimertinib drug tolerant persister cells.Steven W Criscione, Matthew J Martin, Derek B Oien
|Dec 12, 2022
Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer.Sally J Adua, Anna Arnal-Estapé, Minghui Zhao
|Mar 30, 2022
Knowledge graph-based recommendation framework identifies drivers of resistance in EGFR mutant non-small cell lung cancer.Anna Gogleva, Dimitris Polychronopoulos, Matthias Pfeifer
Pageof 2
Frequent Collaborators
2 joint publications
Simon T Barry
2 joint publications
Matthew J Martin
2 joint publications
Courtney L Andersen
2 joint publications
Krishna C Bulusu
2 joint publications
Matthias Pfeifer
2 joint publications
Ultan McDermott
2 joint publications
Darren Cross
1 joint publications
Julio Saez-Rodriguez
1 joint publications
Duncan I Jodrell
1 joint publications
Simon J Cook
